Handelsbanken Fonder’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,400
Closed -$1.07M 1585
2024
Q3
$1.07M Hold
15,400
﹤0.01% 919
2024
Q2
$1.03M Buy
15,400
+4,000
+35% +$269K ﹤0.01% 825
2024
Q1
$786K Hold
11,400
﹤0.01% 950
2023
Q4
$709K Buy
11,400
+3,900
+52% +$218K ﹤0.01% 957
2023
Q3
$421K Hold
7,500
﹤0.01% 1131
2023
Q2
$379K Buy
7,500
+1,300
+21% +$69.2K ﹤0.01% 1226
2023
Q1
$338K Hold
6,200
﹤0.01% 1221
2022
Q4
$388K Buy
6,200
+1,800
+41% +$119K ﹤0.01% 1099
2022
Q3
$310K Hold
4,400
﹤0.01% 1239
2022
Q2
$249K Sell
4,400
-3,400
-44% -$186K ﹤0.01% 1427
2022
Q1
$488K Hold
7,800
﹤0.01% 1220
2021
Q4
$437K Sell
7,800
-5,000
-39% -$306K ﹤0.01% 1443
2021
Q3
$833K Buy
12,800
+4,500
+54% +$307K ﹤0.01% 1012
2021
Q2
$526K Buy
8,300
+3,200
+63% +$189K ﹤0.01% 1344
2021
Q1
$305K Hold
5,100
﹤0.01% 1436
2020
Q4
$255K Buy
+5,100
New +$239K ﹤0.01% 1462

Other funds holding AXNX

Handelsbanken Fonder's AXNX Position: Q4 2024 in Review

Handelsbanken Fonder sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 15,400 shares — an estimated $1.07M sold.

Handelsbanken Fonder first reported a position in AXNX in Q4 2020 and held it in 16 quarters. The position peaked at $1.07M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Handelsbanken Fonder reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Handelsbanken Fonder sold 15,400 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $1.07M.
  • Handelsbanken Fonder first reported a position in Axonics, Inc. Common Stock in Q4 2020 and held it in 16 quarters.
  • Handelsbanken Fonder's Axonics, Inc. Common Stock position peaked at $1.07M in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.